DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo


15.37 0.08 (0.52%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

INSM $15.37 0.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.42
Previous Close $15.29
Daily Range $15.24 - $15.91
52-Week Range $11.25 - $22.29
Market Cap $763.4M
P/E Ratio -8.01
Dividend (Yield) $0.00 (0.0%)
Volume 247,426
Average Daily Volume 568,006
Current FY EPS -$2.07





INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

Sector Update: Health Care

See More INSM News...

INSM's Top Competitors

INSM $15.37 (0.52%)
Current stock: INSM
AMGN $163.46 (1.74%)
Current stock: AMGN
GILD $93.79 (2.74%)
Current stock: GILD
BIIB $342.40 (0.44%)
Current stock: BIIB